DHR vs MA: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Mastercard Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Mastercard Incorporated · Financial Services
$521.30
+95.4% upside to fair value
Grade B
High Quality
QuantHub Verdict
MA has more upside to fair value
(+95.4%).
MA trades at a lower forward P/E
(31.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MA |
| Current Price |
$174.04 |
$521.30 |
| Fair Value Estimate |
$197.01 |
$1,018.59 |
| Upside to Fair Value |
+13.2%
|
+95.4%
|
| Market Cap |
$123.2B |
$465.2B |
| Forward P/E |
33.4x
|
31.2x
|
| EV / EBITDA |
20.3x
|
23.4x
|
| Price / Sales |
5.0x
|
14.2x
|
| Price / FCF |
23.3x
|
27.2x
|
| Revenue Growth YoY |
+3.7%
|
+17.6%
|
| Gross Margin |
60.7%
|
83.4%
|
| Operating Margin |
21.0%
|
59.2%
|
| Return on Equity |
7.1%
|
198.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
3.67%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Mastercard Incorporated operates a leading global payments network and value-added services platform, benefiting from strong secular growth in digital payments and cybersecurity. The company exhibits high business quality with a durable competitive moat supported by network effects, brand strength, and intangible assets. It has demonstrated robust earnings growth with a 21.5% increase in the most…
Accumulation Zones
| Metric |
DHR |
MA |
| Zone Low |
$147.76 |
$763.94 |
| Zone High |
$167.46 |
$865.80 |
| In Buy Zone? |
No
|
Yes
|